Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes

ClinicalTrials.gov ID: NCT03214380

Public ClinicalTrials.gov record NCT03214380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 6:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes PRONTO-T2D

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare LY900014 to insulin lispro, both in combination with insulin glargine or insulin degludec, in participants with type 2 diabetes (T2D).

Study identification

NCT ID
NCT03214380
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
933 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 14, 2017 (Actual)
Primary completion
Aug 14, 2018 (Actual)
Completion
Mar 13, 2019 (Actual)
Last update posted
Mar 27, 2020

2017 – 2019

United States locations

U.S. sites
32
U.S. states
14
U.S. cities
29
Facility City State ZIP Site status
Valley Research Fresno California 93720 —
Diabetes and Endocrine Associates La Mesa California 91942 —
First Valley Medical Group Lancaster California 93534 —
National Research Institute Los Angeles California 90057 —
Care Access Research Santa Clarita California 91321 —
Encompass Clinical Research Spring Valley California 91978 —
University Clinical Investigators, Inc. Tustin California 92780 —
ALL Medical Research, LLC Cooper City Florida 33024 —
The Center For Diabetes & Endocrine Care Fort Lauderdale Florida 33312 —
East Coast Institute For Research Jacksonville Florida 32216 —
Sun Coast Clinical Research, Inc New Port Richey Florida 34652 —
East West Medical Institute Honolulu Hawaii 96814 —
Elite Clinical Trials LLLP Blackfoot Idaho 83221 —
Northwest Clinical Trials Boise Idaho 83704 —
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls Idaho 83404 —
Prairie Education and Research Cooperative Springfield Illinois 62711 —
Iderc, P.L.C. West Des Moines Iowa 50265 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Cotton O'Neil Diabetes and Endocrinology Center Kansas City Kansas 66606 —
Palm Research Center Las Vegas Nevada 89128 —
Palm Research Center Las Vegas Nevada 89148 —
Manhattan Medical Research New York New York 10016 —
Aventiv Research Columbus Ohio 43213 —
Heritage Valley Medical Group, Inc. Beaver Pennsylvania 15009 —
Partners in Nephrology & Endocrinology Pittsburgh Pennsylvania 15224 —
Texas Diabetes and Endocrinology Austin Texas 78731-4309 —
Texas Diabetes and Endocrinology-Austin South Austin Texas 78749 —
Dallas Diabetes Endocrine Center Dallas Texas 75230 —
Consano Clinical Research Shavano Park Texas 78231 —
Progressive Clinical Research Bountiful Utah 84010 —
Private: Dr. Larry Stonesifer Federal Way Washington 98003 —
Rainier Clinical Research Center Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 109 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03214380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 27, 2020 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03214380 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →